How big is the Preventive Vaccines Market?

The Preventive Vaccines Market size is expected to reach USD 89.51 billion in 2024 and grow at a CAGR of 1.42% to reach USD 96.04 billion by 2029. Read More

What is the current Preventive Vaccines Market size?

In 2024, the Preventive Vaccines Market size is expected to reach USD 89.51 billion. Read More

Who are the key players in Preventive Vaccines Market?

AstraZeneca PLC, Emergent BioSolutions Inc, Johnson & Johnson, Merck & Co and GSK Plc are the major companies operating in the Preventive Vaccines Market. Read More

Which is the fastest growing region in Preventive Vaccines Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Preventive Vaccines Market?

In 2024, the North America accounts for the largest market share in Preventive Vaccines Market. Read More

What years does this Preventive Vaccines Market cover, and what was the market size in 2023?

In 2023, the Preventive Vaccines Market size was estimated at USD 88.26 billion. The report covers the Preventive Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Preventive Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Preventive Vaccines Market Report | Industry Analysis, Size & Forecast

Preventive Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Preventive Vaccines Market Growth Trends and is Segmented by Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, MRNA Vaccines, and Other Vaccine Types), Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps, And Rubella (MMR), Covid-19, and Other Disease Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Provides the Value (in USD million) for the Above Segments.

Preventive Vaccines Industry Overview

The preventive vaccines market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the key players in the market are AstraZeneca PLC, Emergent BioSolutions Inc., Daiichi Sankyo Co. Ltd, GSK PLC, Johnson & Johnson, Merck & Co., Novavax Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd, among others.